Presentation TCT 2018

How We Can Utilize the RWE for Regulatory Decision Making? FDA Perspective

Presenter: John C Laschinger

September 22, 2018

REGISTER for free or LOG IN to view this content

How We Can Utilize the RWE for Regulatory Decision Making? FDA Perspective

Policy & Practice

Presentation

TCT 2018

Up Next

Presentation TCT 2018

State-of-the-Art: Medical Therapies for CHF (With a Focus on Diabetes)

Presenter: Ileana L. Pina

September 22, 2018

More slides +

Presentation TCT 2018

State-of-the-Art: Device-based Therapies for CHF

Presenter: Ulrich P. Jorde

September 22, 2018

Presentation TCT 2018

State-of-the-Art: Device and Drug-based Strategies to Reduce the Incidence of Heart Failure Following AMI

Presenter: Navin K. Kapur

September 22, 2018

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.